Objectives-The development and validation of the Center for Neurologic StudyLability Scale (CNS-LS), the first self report measure of aVective lability in patients with amyotrophic lateral sclerosis (ALS). Methods-Potential questionnaire items were identified through interviews with patients and families and expert review. Potential items, as well as measures of aVect intensity, aVective lability in psychopathology, and depression were administered to 99 patients with ALS for item selection and the examination of factor structure and construct validity. Testretest reliability was examined using an additional sample of 31 patients with ALS, and criterion related validity was examined by comparing CNS-LS scores with physicians' diagnoses of aVective lability in a sample of 77 patients with ALS. Results-A seven item questionnaire emerged, composed of two subscales measuring labile laughter (four items) and labile tearfulness (three items). The CNS-LS showed a pattern of associations with aVect intensity, aVective lability in psychopathology, and depression consistent with a scale measuring aVective lability. The CNS-LS also showed good testretest reliability and internal consistency, and successfully predicted physicians' diagnoses of aVective lability. An auxiliary subscale measuring labile frustration, anger, and impatience also emerged. Conclusions-The CNS-LS is a short, easily administered, and psychometrically sound measure of aVective lability for use with patients with ALS. It has potential applications as both a clinical screening device and a research tool. The need for future research into the relation of depression as well as labile frustration, anger, and impatience to the syndrome of aVective lability in neurological disorders is discussed.
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterised by weakness and wasting of skeletal muscle and exaggeration of stretch reflexes. It occurs most commonly in midlife, with a male preponderance, and runs its fatal course in two to three years. Whereas the brunt of the pathological process occurs in the motor cortex, spinal cord, and brainstem, there may also be bilateral involvement of corticobulbar tracts that project on the brainstem. 1 Along with depression many patients with ALS have sudden outbursts of uncontrollable laughter or tearfulness known variously as aVective or emotional lability, pseudobulbar emotionality, or pathological laughter and crying. [2] [3] [4] [5] Such outbursts can occur spontaneously or in response to provocative stimuli such as questions or events. In many cases these displays are dissociated from the patient's underlying mood or emotions, although a lack of consensus as to whether this is necessarily the case is shown by frequent use of both the terms aVective lability and emotionalism in the literature. [6] [7] [8] Irrespective of its origins, this syndrome can have problematic social consequences. These depend to an extent on the frequency and intensity of the behaviour, and in the most extreme cases aVective lability can be disabling, primarily due to the stigma attached to loss of emotional control. A body of evidence suggests that labile aVect can often be modulated through pharmacological intervention. 9 10 The basic mechanisms underlying aVective lability are not well understood. It is known that lesions in various areas in the brain including the frontal and temporal lobes, putamen, and brain stem are all associated with the occurrence of pathological laughter or tearfulness.
11 Whereas this syndrome is most often seen in disorders such as stroke, multiple sclerosis, and ALS, it can occur in association with many other neurological disorders. Presumably, any pathological process that interrupts cortical inhibition of the brain stem may result in this behaviour; thus aVective lability can be considered a disconnection syndrome.
Studies have suggested that pathological aVect occurs in 27% to 49% of patients showing bulbar symptoms of ALS. [12] [13] [14] Research examining the prevalence and incidence of this syndrome has been hampered by the lack of a reliable assessment instrument, with previous studies relying on unstructured interviews, patient records, and non-validated questionnaires. An important first step in the accurate measurement of aVective lability syndrome has been accomplished with the pathological laughter and crying scale, an interviewer administered rating scale validated for use with stroke victims. 15 Another related development has been the aVective lability scale, which measures labile mood and aVect in the context of personality and psychopathology.
There remains the need for a short, easy to administer, self report measure of aVective lability that has been validated for use with patients with ALS. The following study was conducted for the purpose of developing and validating such a measure-the Center for Neurologic Study-Lability Scale (CNS-LS). This study included four groups of patients, and we anticipated that in its final form the CNS-LS would provide a score for overall aVective lability incorporating subscores for labile laughter and labile tearfulness.
Methods
Item generation included interviews with 10 patients with ALS identified by their physicians as having aVective lability or loss of emotional control. Whenever possible, each patient's immediate family members were also interviewed. Participants were asked to identify specific thoughts, feelings, behaviours, and situations that might be associated with this phenomenon. Responses were then used to construct potential questionnaire items. Items were submitted to five neurologists familiar with both ALS and aVective lability for review and suggestions. Fifty seven items were chosen by at least two of the five experts as relevant to the syndrome of aVective lability in ALS and these items were retained. In its final form, each item asks respondents to indicate on the following five point scale how often they experience symptoms of aVective lability: 1 (applies never), 2 (applies rarely), 3 (applies occasionally), 4 (applies frequently), 5 (applies most of the time).
For the purposes of item selection and the examination of factor structure and construct validity, the 57 potential questionnaire items were administered to 99 patients with ALS recruited from six ALS research and treatment centres in the United States and Canada. The mean age of participants was 57.79 (SD 13.38) years, and 69 were male. Construct validity of the CNS-LS was examined by determining its convergent and discriminant relations with three other measures. Fifty five of the 99 participants completed the anxiety, depression, and anger subscales of the aVective lability scale. To the degree the constructs of aVective lability in psychopathology and aVective lability in ALS overlap, especially symptomatically, the CNS-LS and the aVective lability scale should be associated. Thirty five participants completed the aVect intensity measure, a measure of the intensity with which an individual experiences aVects in general. 17 Previous research has shown the intensity of aVect to be unrelated to labile aVect and mood. 18 Seventy two participants completed the Beck depression inventory, a widely used measure of state depression. 19 Previous studies examining the relation between aVective lability and mood disorder have focused on stroke patients, producing mixed results. 20 21 As a result, no predictions were made regarding the relation of depressed mood to the CNS-LS, although it was expected that if an association were present it would be between depression and the portion of the CNS-LS measuring labile tearfulness.
To assess test-retest reliability, the final version of the CNS-LS that emerged after item selection was administered to 31 patients with ALS recruited from the Center for Neurologic Study, San Diego, California, at one to two week intervals. The mean age of participants was 61.81 (SD 13.21) years, and 21 were male.
To determine criterion related validity, 77 patients with ALS, 51 from the Center for Neurologic Study and 26 from the University of Kentucky, also completed the final version of the CNS-LS. The mean age of participants was 55.21 (SD 14.10) years, and 47 were male. A neurologist (one for the Center for Neurologic Study sample, and one for the University of Kentucky sample) diagnosed each participant for presence or absence of labile aVect based on both clinical history and neurological examination. Criteria for the diagnosis of lability were sudden outbursts of laughter, crying, or other strong aVect that occurred spontaneously, or were inappropriate given the context.
Results

ITEM SELECTION AND FACTORIAL STRUCTURE
Factor structure of the 57 potential questionnaire items was examined using principal components analysis with varimax rotation. Scree slope analysis (see end note 1) identified three underlying factors, accounting for 76.6% of the variance. Factor 1 accounted for 49.7% of the variance and consisted of eight items that assess labile frustration, impatience, and anger. Factor 2 contained four items, which accounted for 16.7% of the variance, and these were conceptually related to pathological laughter. Factor 3 contained three items assessing labile tearfulness and accounted for 10.2% of the variance.
The construct of aVective lability has up to now encompassed the symptoms of both pathological laughter and pathological tearfulness, but not the labile expression of anger, frustration, or impatience. Therefore, it was decided for theoretical reasons that factor 2, measuring labile laughter and factor 3, measuring labile tearfulness, should be retained as separate subscales comprising the seven item CNS-LS. Factor 1, measuring a combination of labile frustration, anger, and impatience, was retained as an auxiliary subscale for the purpose of exploring the relevance of these symptoms to aVective lability in ALS (See appendix A and appendix B for factor 1 items and psychometric values).
A second principal components analysis was performed on the seven items comprising the CNS-LS. Two factors emerged, identical in item content to the labile laughter and tearfulness subscales identified in the previous analysis, and together these accounted for 80.2% of the total variance. The factor containing the four labile laughter subscale items accounted for 56.4% of the variance, whereas the factor containing the three items from the labile tearfulness subscale accounted for 23.9% of the variance. Tables 1 and 2 present the resulting seven items and factor loadings. Table 3 gives the factor eigenvalues and percentages of variance.
Cronbach's was used to measure internal consistency of the CNS-LS, with a resulting coeYcient of 0.91 for the laughter subscale, 0.89 for the tearfulness subscale, and 0.87 for the entire questionnaire.
CONSTRUCT VALIDITY Table 4 shows that as predicted, total scores for the seven item CNS-LS were significantly associated with the aVective lability scale (r = 0.41, P < 0.01). As also predicted, the CNS-LS showed no association with aVective intensity measure scores (P > 0.05). The CNS-LS was significantly associated with Beck depression inventory scores (r = 0.24, P < 0.05). As would be expected, the tearfulness subscale of the CNS-LS showed an association with Beck depression inventory scores (r = 0.39, P < 0.01), whereas the laughter subscale did not.
TEST-RETEST RELIABILITY CNS-LS total scores showed a test-retest reliability of 0.88.
CRITERION VALIDITY
Physicians rated 46 of 77 participants as showing meaningful symptoms of aVective lability, with the remaining 31 participants showing few or no symptoms of lability. Mean CNS-LS total scores were significantly higher in the labile group (18.46 (SD 6.32)) than in the non-labile group (10.19 (SD 3.45)) (t (75) = 6.64, P < 0.001). In addition, mean tearfulness subscale scores were significantly higher in the labile group (9.67 (SD 3.31)) than in the nonlabile group (4.45 SD (1.88)) (t (75) = 7.98, P < 0.001), and mean laughter subscale scores were significantly higher in the labile group (8.76 (SD 4.34)) than in the non-labile group (5.74 (SD 2.27)) (t (75) = 3.56, P = 0 001). Cutting scores for the identification of affective lability using CNS-LS total scores were designated, and categorisations based on these scores were compared with neurologists' diagnoses for the purpose of examining criterion related validity. A cutting score of 13 and above was chosen for situations in which the CNS-LS is to be used for general research purposes because it provided the highest incremental validity (see end note 2). Using this cut oV CNS-LS total scores accurately predicted neurologists' diagnoses for 82% of participants in the current sample, with a sensitivity of 0.84 and a specifity of 0.81. Assuming a prevalence rate for aVective lability between 27% and 49% this resulted in an incremental validity ranging from 0.34 to 0.31 and a negative predictive value ranging from 0.92 to 0.84. The less stringent cutting score of 11 and above was chosen for instances when the CNS-LS is to be used for clinical screening and this cut oV predicted neurologists' diagnoses with a sensitivity of 0.91 and a specificity of 0.71. This results in an incremental validity ranging from 0.27 to 0.26 and a negative predictive value ranging from 0.96 to 0.90.
Using a cutting score of 13 and above the data set used for item selection and the examination of factor structure and construct validity was reanalysed for the purpose of exploring further the relation between affective lability as measured by the CNS-LS and depression. Table 5 indicates that 66 patients completed both the CNS-LS and the Beck depression inventory, with 36 of these scoring in the labile range on the CNS-LS, and 30 scoring in the non-labile range. Further inspection showed that 11 of 36 (31%) labile patients had significant levels of depression on the Beck depression inventory, compared with six of 30 (20%) non-labile patients.
Discussion
The research reported here has resulted in the development and validation of the CNS-LS, the first self report measure of pathological aVect for use with patients with ALS. The CNS-LS is short (seven items), easy to administer, and provides a quantitative measure of perceived frequency of aVective lability incorporating subscales measuring labile laughter and labile tearfulness. It shows high internal consistency and test-retest reliability. In addition, the CNS-LS successfully predicts neurologists' diagnoses of aVective lability and shows a convergent and discriminant pattern of relations with aVect intensity and aVective lability in psychopathology that is consistent with an instrument that is measuring labile laughter and tearfulness. Little is currently known about the relation between mood and aVective lability in ALS. In our sample, CNS-LS scores showed a modest but significant correlation with depression scores. Our own clinical findings suggest that the psychological and interpersonal consequences of loss of aVective control can often be a considerable source of distress to both patients and their families, and for this reason an association between the CNS-LS and depression is not surprising. In addition, both aVective lability and depressed mood are significantly associated with ALS, and for this reason alone it would not be surprising if aVective lability and depression were in turn themselves associated. On the other hand, drugs that are useful in reducing aVective lability typically produce significant eVects within a matter of days, whereas pharmacological interventions for depression typically require weeks to achieve significant results, a discrepancy that argues against a syndromal association between aVective lability and depression. 9 10 Several methodological factors in particular limit the interpretability of the current study regarding this topic. For example, the number of participants assessed for both aVective lability and mood was small, and because complete medical histories were not available in all cases it is possible that some participants in this study had a pre-existing depression, or were receiving antidepressant or other mood altering medications. In addition, because of methodological limitations it was necessary to use a self report measure of depression, the Beck depression inventory, even though several of its items may confound the measurement of depressed mood with behavioural and physical limitations which are common among those with ALS. It is important to note that from a psychometric perspective the association noted between CNS-LS scores and depression has little practical eVect on the utility of our scale as variability in depression scores accounted for only 6% of the variance in CNS-LS scores in the sample examined. More carefully controlled research into the relation between aVective lability and depressed mood in ALS is required.
As with depressed mood, the possible role of labile frustration, anger, and impatience in aVective lability in ALS is also unclear. In the course of interviewing patients and their families the symptoms of labile frustration, anger, and impatience were often mentioned in conjunction with the syndrome of aVective lability. Items measuring these symptoms were included in our original item pool because they were judged by at least two of five neurologists familiar with aVective lability and ALS as being relevant to this syndrome. Further, research with patients with ALS using the CNS-LS has indicated that a combination of the drugs dextromethorphan and quinidine is eVective in reducing scores on the auxiliary subscale measuring labile frustration, anger, and impatience as well as the labile laughter and tearfulness subscales. This provides further evidence for a syndromal association between these factors. 10 Robinson et al also recognised the possible role of labile anger in aVective lability by incorporating an item assessing that symptom in their pathological laughter and crying scale. Psychometric data for the auxiliary subscale, however, provides only mixed support for the proposition that labile frustration, anger, and impatience are indeed components of aVective lability in ALS. Whereas auxiliary subscale scores were significantly correlated with physicians' diagnoses, they were more strongly correlated with depression. Further, when auxiliary subscale scores were added to the CNS-LS this led to reductions in both its correlation with physicians' diagnoses, and its predictive utility, although this may be the result of a failure on the part of physicians to take the symptoms of labile frustration, anger, and impatience into account when diagnosing aVective lability. More research is needed into the possible role of labile frustration, anger, and impatience in the syndrome of aVective lability in ALS.
As the first self report measure of aVective lability validated for use with neurological patients the CNS-LS has both research and clinical applications. Its ability to accurately determine the presence or absence of aVective lability should facilitate research into the prevalence and incidence of this syndrome, whereas also providing a simple, convenient, and reliable dependent measure for use in treatment outcome studies. Because of its ability to accurately identify patients with ALS who are demonstrating symptoms of lability the CNS-LS is attractive as a screening device as well. In this regard it is noteworthy that the CNS-LS classified as aVectively labile a number of patients identified as normal by physician diagnosis. Whereas these cases may represent false positives, they also raise the possibility that the CNS-LS may be useful in identifying patients with aVective lability who would otherwise go undetected by diagnostic interview alone. It may also identify as aVectively labile patients who would otherwise be misdiagnosed with depression or other psychiatric disorders. It is hoped that future studies will examine the validity of the CNS-LS for multiple sclerosis and stroke patients. Such studies may also clarify the degree to which the expression of labile aVect is similar or dissimilar across various neurological disorders.
